Evidence map›Paper›PMID 39727858›Full record

ReviewBiosensors2024

Towards Point-of-Care Single Biomolecule Detection Using Next Generation Portable Nanoplasmonic Biosensors: A Review.

Saeed Takaloo, Alexander H Xu, Liena Zaidan, Mehrdad Irannejad, Mustafa Yavuz

Abstract readReview
In one paragraph

Review in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saeed TakalooDepartment of Mechanical and Mechatronics Engineering, University of Waterloo, 200 University Ave. West, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0002-8674-3969
Alexander H XuWaterloo Institute for Nanotechnology (WIN), University of Waterloo, 200 University Ave. West, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0002-3853-1494
Liena ZaidanWaterloo Institute for Nanotechnology (WIN), University of Waterloo, 200 University Ave. West, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0002-4685-965X
Mehrdad IrannejadOZ Optics Ltd., Ottawa, ON K0A 1L0, Canada.ORCID 0000-0002-2180-5671
Mustafa YavuzDepartment of Mechanical and Mechatronics Engineering, University of Waterloo, 200 University Ave. West, Waterloo, ON N2L 3G1, Canada.ORCID 0009-0001-9179-9107

Funding

Mitacs N.A.Natural Sciences and Engineering Research Council N.A.
6 · The paper itself

Abstract

Over the past few years, nanoplasmonic biosensors have gained widespread interest for early diagnosis of diseases thanks to their simple design, low detection limit down to the biomolecule level, high sensitivity to even small molecules, cost-effectiveness, and potential for miniaturization, to name but a few benefits. These intrinsic natures of the technology make it the perfect solution for compact and portable designs that combine sampling, analysis, and measurement into a miniaturized chip. This review summarizes applications, theoretical modeling, and research on portable nanoplasmonic biosensor designs. In order to develop portable designs, three basic components have been miniaturized: light sources, plasmonic chips, and photodetectors. There are five types of portable designs: portable SPR, miniaturized components, flexible, wearable SERS-based, and microfluidic. The latter design also reduces diffusion times and allows small amounts of samples to be delivered near plasmonic chips. The properties of nanomaterials and nanostructures are also discussed, which have improved biosensor performance metrics. Researchers have also made progress in improving the reproducibility of these biosensors, which is a major obstacle to their commercialization. Furthermore, future trends will focus on enhancing performance metrics, optimizing biorecognition, addressing practical constraints, considering surface chemistry, and employing emerging technologies. In the foreseeable future, these trends will be merged to result in portable nanoplasmonic biosensors offering detection of even a single biomolecule.

Indexed as

Biosensing TechniquesPoint-of-Care SystemsHumansNanostructuresNanotechnologySurface Plasmon Resonancelab-on-a-chipmicro/nano-optics biosensornanoplasmonicplasmonic materialspoint-of-care testSPR

Identifiers

PMID39727858
PMCPMC11674598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.